Current and Prospective Applications of CRISPR-Cas12a in Pluricellular Organisms

被引:0
|
作者
Shaheen Khan
Erwan Sallard
机构
[1] Università degli Studi di Milano,Department of Molecular Biotechnology and Bioinformatics
[2] Vita-Salute San Raffaele University and Hospital,Division of Neuroscience, Department of Pharmacology & Toxicology
[3] Witten/Herdecke University,Center for Biomedical Education and Research (ZBAF), Department of Human Medicine, Faculty of Health, Institute for Virology and Microbiology
来源
Molecular Biotechnology | 2023年 / 65卷
关键词
CRISPR-Cas12a; Cpf1; Genome editing; Multiplex gene editing; Gene therapy; Plant biotechnology;
D O I
暂无
中图分类号
学科分类号
摘要
CRISPR-Cas systems play a critical role in the prokaryotic adaptive immunity against mobile genetic elements, such as phages and foreign plasmids. In the last decade, Cas9 has been established as a powerful and versatile gene editing tool. In its wake, the novel RNA-guided endonuclease system CRISPR-Cas12a is transforming biological research due to its unique properties, such as its high specificity or its ability to target T-rich motifs, to induce staggered double-strand breaks and to process RNA arrays. Meanwhile, there is an increasing need for efficient and safe gene activation, repression or editing in pluricellular organisms for crop improvement, gene therapy, research model development, and other goals. In this article, we review CRISPR-Cas12a applications in pluricellular organisms and discuss how the challenges characteristic of these complex models, such as vectorization or temperature variations in ectothermic species, can be overcome.
引用
收藏
页码:196 / 205
页数:9
相关论文
共 50 条
  • [21] Broad-spectrum enzymatic inhibition of CRISPR-Cas12a
    Gavin J. Knott
    Brittney W. Thornton
    Marco J. Lobba
    Jun-Jie Liu
    Basem Al-Shayeb
    Kyle E. Watters
    Jennifer A. Doudna
    Nature Structural & Molecular Biology, 2019, 26 : 315 - 321
  • [22] An ultrasensitive homogeneous electrochemical biosensor based on CRISPR-Cas12a
    Liu, Jie
    Wan, Qing
    Zeng, Ruijin
    Tang, Dianping
    ANALYTICAL METHODS, 2021, 13 (29) : 3227 - 3232
  • [23] DNA Origami Post-Processing by CRISPR-Cas12a
    Xiong, Qiancheng
    Xie, Chun
    Zhang, Zhao
    Liu, Longfei
    Powell, John T.
    Shen, Qi
    Lin, Chenxiang
    Advanced Materials, 2020, 59 (10) : 3984 - 3988
  • [24] Broad-spectrum enzymatic inhibition of CRISPR-Cas12a
    Knott, Gavin J.
    Thornton, Brittney W.
    Lobba, Marco J.
    Liu, Jun-Jie
    Al-Shayeb, Basem
    Watters, Kyle E.
    Doudna, Jennifer A.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2019, 26 (04) : 315 - +
  • [25] DNA Origami Post-Processing by CRISPR-Cas12a
    Xiong, Qiancheng
    Xie, Chun
    Zhang, Zhao
    Liu, Longfei
    Powell, John T.
    Shen, Qi
    Lin, Chenxiang
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (10) : 3956 - 3960
  • [26] Development of a CRISPR-Cas12a rapid diagnostic for human cytomegalovirus
    Monk, Chandler H.
    Youngquist, Brady M.
    Brady, Alyson D.
    Shaffer, Jeffrey G.
    Hu, Tony Y.
    Ning, Bo
    Zwezdaryk, Kevin J.
    ANTIVIRAL RESEARCH, 2023, 215
  • [27] CRISPR-Cas12a system in fission yeast for multiplex genomic editing and CRISPR interference
    Zhao, Yu
    Boeke, Jef D.
    NUCLEIC ACIDS RESEARCH, 2020, 48 (10) : 5788 - 5798
  • [28] Improving the use of CRISPR-Cas12a (Cpf1) in cyanobacteria
    Guevara Acosta, F. G.
    Baldanta, S.
    Navarro-Llorens, J.
    FEBS OPEN BIO, 2021, 11 : 62 - 62
  • [29] Heterologous Expression and Purification of CRISPR-Cas12a/Cpf1
    Mohanraju, Prarthana
    van der Oost, John
    Jinek, Martin
    Swarts, Daan C.
    BIO-PROTOCOL, 2018, 8 (09):
  • [30] Induction of HbF Using Improved CRISPR-Cas12a Base Editor
    Stella, Stefano
    Wan, Haixia
    Perez, Alex
    MOLECULAR THERAPY, 2024, 32 (04) : 348 - 348